Summary:
This research study is studying zavegepant as a possible treatment for chronic migraine and to determine the effectiveness of zavegepant as a preventive treatment for chronic migraine. This is measured by counting the number of migraine days you have each month. This is a double-blind study, which means neither you nor the study doctor will know if you were assigned zavegepant or placebo (a substance that looks like the zavegepant but has no active drug in it).
Qualified Participants Must:
• Participants must be Aged 18+ years
• and have a history of chronic migraine headaches for at least one year
Qualified Participants May Receive:
Reimbursement for time and travel related to study participation may be provided.